2 Nasdaq 100 Stocks for Long-Term Investors and 1 We Turn Down
The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability concerns, rising costs, or shifts in market trends.
Investing in Nasdaq 100 stocks isn’t just about picking big names - it’s about finding the right ones, and that’s where StockStory comes in. Keeping that in mind, here are two Nasdaq 100 stocks that could lead the market and one that may struggle.
One Stock to Sell:
Mondelez (MDLZ)
Market Cap: $77.66 billion
Founded as Nabisco in 1903, Mondelez (NASDAQ:MDLZ) is a packaged snacks powerhouse best known for its Oreo, Cadbury, Toblerone, Ritz, and Trident brands.
Why Are We Cautious About MDLZ?
- Declining unit sales over the past two years show it’s struggled to move its products and had to rely on price increases
- Estimated sales growth of 2.6% for the next 12 months implies demand will slow from its three-year trend
- Incremental sales over the last three years were much less profitable as its earnings per share fell by 3% annually while its revenue grew
At $61.04 per share, Mondelez trades at 19.2x forward P/E. To fully understand why you should be careful with MDLZ, check out our full research report (it’s free).
Two Stocks to Watch:
Western Digital (WDC)
Market Cap: $159.1 billion
Founded in 1970 by a Motorola employee, Western Digital (NASDAQ: WDC) is a leading producer of hard disk drives, SSDs and flash memory.
Why Are We Fans of WDC?
- Sales outlook for the upcoming 12 months calls for 48.3% growth, an acceleration from its two-year trend
- Operating margin improved by 21.7 percentage points over the last five years as it eliminated redundant costs
- Free cash flow margin jumped by 23.1 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
Western Digital’s stock price of $442.40 implies a valuation ratio of 20.9x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free.
DexCom (DXCM)
Market Cap: $33.72 billion
Founded in 1999 and receiving its first FDA approval in 2006, DexCom (NASDAQ:DXCM) develops and sells continuous glucose monitoring systems that allow people with diabetes to track their blood sugar levels without repeated finger pricks.
Why Are We Bullish on DXCM?
- Core business can prosper without any help from acquisitions as its organic revenue growth averaged 12% over the past two years
- Free cash flow margin grew by 20.2 percentage points over the last five years, giving the company more chips to play with
- Rising returns on capital show management is finding more attractive investment opportunities
DexCom is trading at $89.88 per share, or 31.2x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.